Department of Integrated Biological Science, Pusan National University, Busan 46241, Korea.
Laboratory of Low Dose Risk Assessment, National Radiation Emergency Medical Center, Korea Institute of Radiological & Medical Sciences, Seoul 01812, Korea.
Cells. 2020 Apr 2;9(4):861. doi: 10.3390/cells9040861.
Epithelial-mesenchymal transition (EMT) causes epithelial cells to lose their polarity and adhesion property, and endows them with migratory and invasive properties to enable them to become mesenchymal stem cells. EMT occurs throughout embryonic development, during wound healing, and in various pathological processes, including tumor progression. Considerable research in the last few decades has revealed that EMT is invariably related to tumor aggressiveness and metastasis. Apart from the interactions between numerous intracellular signaling pathways known to regulate EMT, extracellular modulators in the tumor microenvironment also influence tumor cells to undergo EMT, with extracellular vesicles (EVs) receiving increasing attention as EMT inducers. EVs comprise exosomes and microvesicles that carry proteins, nucleic acids, lipids, and other small molecules to stimulate EMT in cells. Among EVs, exosomes have been investigated in many studies, and their role has been found to be significant with respect to regulating intercellular communications. In this review, we summarize recent studies on exosomes and their cargoes that induce cancer-associated EMT. Furthermore, we describe the possible applications of exosomes as promising therapeutic strategies.
上皮-间充质转化(EMT)导致上皮细胞失去极性和黏附特性,并赋予其迁移和侵袭特性,使其成为间充质干细胞。EMT 发生在整个胚胎发育过程中,在伤口愈合过程中,以及在各种病理过程中,包括肿瘤进展。在过去几十年的大量研究中揭示,EMT 与肿瘤侵袭性和转移密切相关。除了已知调节 EMT 的众多细胞内信号通路之间的相互作用外,肿瘤微环境中的细胞外调节剂也影响肿瘤细胞发生 EMT,细胞外囊泡(EVs)作为 EMT 诱导物受到越来越多的关注。EVs 包括携带蛋白质、核酸、脂质和其他小分子的外泌体和微囊泡,以刺激细胞发生 EMT。在 EVs 中,外泌体已在许多研究中进行了研究,并且发现它们在调节细胞间通讯方面具有重要作用。在这篇综述中,我们总结了最近关于诱导癌症相关 EMT 的外泌体及其货物的研究。此外,我们还描述了外泌体作为有前途的治疗策略的可能应用。
Cells. 2020-4-2
Semin Cell Dev Biol. 2015-2-23
Nan Fang Yi Ke Da Xue Xue Bao. 2019-3-30
ACS Appl Bio Mater. 2024-1-15
Biochem Biophys Res Commun. 2016-9-16
Int J Cancer. 2025-8-1
J Transl Med. 2025-4-26
Int J Mol Sci. 2024-7-25
Transl Cancer Res. 2024-6-30
J Transl Med. 2020-2-3
J Extracell Vesicles. 2019-11-15